Terms: = Cervical cancer AND IRF4, LSIRF, 3662, ENSG00000137265, Q15306
11 results:
1. Knowledge of cervical cancer, human papillomavirus (HPV), and acceptance of the HPV vaccine among parents of daughters in Riyadh, Saudi Arabia.
Alherz FA; Alamri AA; Aljbreen A; Alwallan N
J Infect Public Health; 2024 May; 17(5):789-794. PubMed ID: 38520759
[TBL] [Abstract] [Full Text] [Related]
2. The Immune-related ceRNA Network in Prognosis of cervical cancer.
Dhandapani H; Bose M; Kesavan S
Asian Pac J Cancer Prev; 2022 Oct; 23(10):3347-3354. PubMed ID: 36308358
[TBL] [Abstract] [Full Text] [Related]
3. Overexpression of long non-coding RNA WT1-AS or silencing of PIK3AP1 are inhibitory to cervical cancer progression.
Tong W; Zhang H
Cell Cycle; 2021 Dec; 20(24):2583-2596. PubMed ID: 34839795
[TBL] [Abstract] [Full Text] [Related]
4. Hsa_circ_0000301 facilitates the progression of cervical cancer by targeting miR-1228-3p/irf4 Axis.
Deng ZM; Dai FF; Zhou Q; Cheng YX
BMC Cancer; 2021 May; 21(1):583. PubMed ID: 34020619
[TBL] [Abstract] [Full Text] [Related]
5. The D2 and D3 Sublineages of Human Papilloma Virus 16-Positive cervical cancer in Guatemala Differ in Integration Rate and Age of Diagnosis.
Lou H; Boland JF; Torres-Gonzalez E; Albanez A; Zhou W; Steinberg MK; Diaw L; Mitchell J; Roberson D; Cullen M; Garland L; Bass S; Burk RD; Yeager M; Wentzensen N; Schiffman M; Freites EA; Gharzouzi E; Mirabello L; Dean M
Cancer Res; 2020 Sep; 80(18):3803-3809. PubMed ID: 32631904
[TBL] [Abstract] [Full Text] [Related]
6. Highly immunosuppressive HLADR
Yang H; Ye S; Goswami S; Li T; Wu J; Cao C; Ma J; Lu B; Pei X; Chen Y; Yu J; Xu H; Qiu L; Afridi S; Xiang L; Zhang X
Int J Cancer; 2020 Apr; 146(7):1993-2006. PubMed ID: 31709528
[TBL] [Abstract] [Full Text] [Related]
7. Patient concerns about human papillomavirus testing and 5-year intervals in routine cervical cancer screening.
Silver MI; Rositch AF; Burke AE; Chang K; Viscidi R; Gravitt PE
Obstet Gynecol; 2015 Feb; 125(2):317-329. PubMed ID: 25568994
[TBL] [Abstract] [Full Text] [Related]
8. Epigenetic and genetic alternation of PTEN in cervical neoplasm.
Cheung TH; Lo KW; Yim SF; Chan LK; Heung MS; Chan CS; Cheung AY; Chung TK; Wong YF
Gynecol Oncol; 2004 Jun; 93(3):621-7. PubMed ID: 15196854
[TBL] [Abstract] [Full Text] [Related]
9. An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV).
Castle PE; Hillier SL; Rabe LK; Hildesheim A; Herrero R; Bratti MC; Sherman ME; Burk RD; Rodriguez AC; Alfaro M; Hutchinson ML; Morales J; Schiffman M
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1021-7. PubMed ID: 11588127
[TBL] [Abstract] [Full Text] [Related]
10. High resolution mapping of chromosome 6 deletions in cervical cancer.
Mazurenko N; Attaleb M; Gritsko T; Semjonova L; Pavlova L; Sakharova O; Kisseljov F
Oncol Rep; 1999; 6(4):859-63. PubMed ID: 10373671
[TBL] [Abstract] [Full Text] [Related]
11. Modulation of receptors and cytotoxic response of tumor necrosis factor-alpha by various lectins.
Aggarwal BB; Traquina PR; Eessalu TE
J Biol Chem; 1986 Oct; 261(29):13652-6. PubMed ID: 3020039
[TBL] [Abstract] [Full Text] [Related]
